التفاصيل البيبلوغرافية
العنوان: |
application of natural compounds in uveal melanoma drug discovery. |
المؤلفون: |
Niu, Yihe, Wang, Ke, Zhu, Xue, Zhang, Stanley, Cherepanoff, Svetlana, Conway, R Max, Madigan, Michele C, Lim, Li-Anne, Zhu, Ling, Murray, Michael, Zhou, Fanfan |
المصدر: |
Journal of Pharmacy & Pharmacology; May2022, Vol. 74 Issue 5, p660-680, 21p |
مصطلحات موضوعية: |
DRUG discovery, MELANOMA, SURVIVAL rate, DRUG therapy, ZEAXANTHIN, IPILIMUMAB |
مستخلص: |
Objectives Uveal melanoma (UM) is the most common primary intraocular tumour in adults. UM has a poor overall prognosis and ~50% of patients progress to metastatic disease that has a median survival of 5.2 months. There are currently no proven pharmacological treatments for primary or metastatic UM. Research efforts continue to seek new agents. Many natural compounds have shown promising anti-UM activity in in-vitro and/or in-vivo studies. This review summarises the current findings for natural compounds that may be potentially useful in treating UM. Key findings Literature suggests that natural compounds, such as pristimerin, picropodophyllin, oridonin, zeaxanthin, withaferin and FR-900359, may be promising candidate compounds to treat UM. Most of these compounds have demonstrated satisfactory efficacy in inhibiting in-vitro UM cell growth. Summary The evidence regarding the anti-UM effects of natural compounds is mainly limited to in-vitro studies; to date, only a small number of these agents have been evaluated in vivo. The molecular mechanisms underpinning the anti-UM properties of these compounds remain largely undefined. Further studies are required to evaluate the in-vivo anticancer activity, appropriate dosage regimen and safety of natural compounds that could be developed for use in UM. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Pharmacy & Pharmacology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |